#Itolizumab

A thread on Data presented in support of Itolizumab at press conference yesterdayYou can watch the conference here:(Discussion of Results starts at 29 minutes)https://m.youtube.com/watch?v=pWWmJKWa-qA&t=29m&feature=youtu.be My take

The 23 March 2021 COVID treatment guidelines of Maharashtra govt, as the state sees a huge surge. Vitamin D, Favipiravir and HCQ reccomended for mild cases Convalescent plasma for moderate

A tweet thread.Subject: Critical appraisal of Itolizumab in #Coronavirus infection. Events: 1. @sardesairajdeep ran a programme on 11 July showcasing what was claimed to be a breakthrough in the hunt

सिद्धार्थ

PHARMA, do it @Bioconlimited way! Register trial for sample size X, do OFF-LABEL w/ sample size Y≫ X, e.g., Y=150, X=30. SAVE LOT of MONEY. Stop clinical trial if OFF-LABEL

सिद्धार्थ

Restricted Use of #Itolizumab for CRS in moderate to severe ARDS patients due to #COVID19. No peer-review.Phase III clinical trial exempted, to go for Phase IV. Wordings of SEC meeting

सिद्धार्थ

@BioconBiologics modified CTRI/2020/05/024959 #Itolizumab #COVID19 on Aug 20, 2020 (> 40 days of trial completion). ( this thread) Results Submitted to http://ClinicalTrials.gov on Aug 2 and Results Returned after Quality

“Another spectacular failure of the administration has been not to heed its own disease models. As far back as late February, we knew that the virus was spreading in the

Dr. Jonathan 🇮🇳👨‍⚕️⚕️

just1doctorwala

For those of you who don't understand why so many of us medicos are questioning the drug Itolizumab the company Biocon and Ms. Kiran Shaw let me explain.#ThreadAlert Issue 1.

It's not often that I disagree with Dr. P @netshrink but in this instance, I will. Back story: As the C-19 wave 2 runs amok in India, medical management has